Joanne M. Hackett - Feb 2, 2022 Form 4 Insider Report for AgeX Therapeutics, Inc. (AGE)

Role
Director
Signature
/s/Joanne M. Hackett
Stock symbol
AGE
Transactions as of
Feb 2, 2022
Transactions value $
$0
Form type
4
Date filed
2/4/2022, 03:50 PM
Previous filing
Jan 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Option to Purchase Common Stock Award $0 +65K $0.00 65K Feb 2, 2022 Common Stock 65K $0.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options will vest and become exercisable in four equal quarterly installments on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, provided that the grantee remains a director on the last day of the applicable calendar quarter.